Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.

Saved in:
Bibliographic Details
Title: Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US.
Authors: Burdis NC; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States., Bradford MC; Seattle Children's Research Institute, Biostatics Epidemiology and Analytics in Research (BEAR) Core, Seattle, WA, United States., Heltshe SL; Division of Pulmonary and Allergy, Department of Pediatrics, University of Washington, Seattle WA, United States; CFF TDNCC Seattle Children's Research Institute, Seattle, WA, United States., Milinic T; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States., McElvaney OJ; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States., Lease ED; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States., Goss CH; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States; Division of Pulmonary and Allergy, Department of Pediatrics, University of Washington, Seattle WA, United States; CFF TDNCC Seattle Children's Research Institute, Seattle, WA, United States., Kapnadak SG; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States., Guthrie BL; School of Public Health, Department of Global Health, University of Washington, Seattle, WA, United States., Ramos KJ; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle WA, United States; CFF TDNCC Seattle Children's Research Institute, Seattle, WA, United States. Electronic address: ramoskj@uw.edu.
Source: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2025 Sep; Vol. 24 (5), pp. 929-934. Date of Electronic Publication: 2025 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5010
DOI:10.1016/j.jcf.2025.06.005